Literature DB >> 19626383

Shoulder arthroplasties have fewer complications than hip or knee arthroplasties in US veterans.

Edward V Fehringer1, Ted R Mikuls, Kaleb D Michaud, William G Henderson, James R O'Dell.   

Abstract

UNLABELLED: Total shoulder arthroplasties (TSA) are being performed more commonly for treatment of arthritis, although fewer than either hip (THA) or knee (TKA) arthroplasties. Total shoulder arthroplasty also provides general health improvements that are comparable to THA. One study suggests TSAs are associated with lower morbidity and mortality than THAs and TKAs. To confirm and extend that study, we therefore examined the association of patient characteristics (sociodemographics, comorbid illness, and other risk factors) with 30-day complications for patients undergoing TSAs, THAs, or TKAs. We used data from the Veterans Administration (VA) National Surgical Quality Improvement Program (NSQIP) for fiscal years 1999 to 2006. Sociodemographics, comorbidities, health behaviors, operative factors, and complications (mortality, return to the operating room, readmission within 14 days, cardiovascular events, and infections) were available for 10,407 THAs, 23,042 TKAs, and 793 TSAs. Sociodemographic features were comparable among groups. The mean operative time was greater for TSAs (3.0 hours) than for TKAs (2.2 hours) and THAs (2.4 hours). The 30-day mortality rates were 1.2%, 1.1%, and 0.4% for THAs, TKAs, and TSAs, respectively. The corresponding postoperative complication rates were 7.6%, 6.8%, and 2.8%. Adjusting for multiple risk factors, complications, readmissions, and postoperative stays were less for TSAs versus THAs and TKAs. In a VA population, TSAs required more operative time but resulted in shorter stays, fewer complications, and fewer readmissions than THAs and TKAs. LEVEL OF EVIDENCE: Level III, therapeutic study. See the Guidelines for Authors for a complete description of levels of evidence.

Entities:  

Mesh:

Year:  2009        PMID: 19626383      PMCID: PMC2816783          DOI: 10.1007/s11999-009-0996-2

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  14 in total

Review 1.  A primer and comparative review of major US mortality databases.

Authors:  Diane C Cowper; Joseph D Kubal; Charles Maynard; Denise M Hynes
Journal:  Ann Epidemiol       Date:  2002-10       Impact factor: 3.797

2.  Risk adjustment of the postoperative mortality rate for the comparative assessment of the quality of surgical care: results of the National Veterans Affairs Surgical Risk Study.

Authors:  S F Khuri; J Daley; W Henderson; K Hur; J O Gibbs; G Barbour; J Demakis; G Irvin; J F Stremple; F Grover; G McDonald; E Passaro; P J Fabri; J Spencer; K Hammermeister; J B Aust
Journal:  J Am Coll Surg       Date:  1997-10       Impact factor: 6.113

3.  The Department of Veterans Affairs' NSQIP: the first national, validated, outcome-based, risk-adjusted, and peer-controlled program for the measurement and enhancement of the quality of surgical care. National VA Surgical Quality Improvement Program.

Authors:  S F Khuri; J Daley; W Henderson; K Hur; J Demakis; J B Aust; V Chong; P J Fabri; J O Gibbs; F Grover; K Hammermeister; G Irvin; G McDonald; E Passaro; L Phillips; F Scamman; J Spencer; J F Stremple
Journal:  Ann Surg       Date:  1998-10       Impact factor: 12.969

4.  Validating risk-adjusted surgical outcomes: site visit assessment of process and structure. National VA Surgical Risk Study.

Authors:  J Daley; M G Forbes; G J Young; M P Charns; J O Gibbs; K Hur; W Henderson; S F Khuri
Journal:  J Am Coll Surg       Date:  1997-10       Impact factor: 6.113

5.  Functional outcome after shoulder arthroplasty for primary osteoarthritis: a multicenter study.

Authors:  Tom R Norris; Joseph P Iannotti
Journal:  J Shoulder Elbow Surg       Date:  2002 Mar-Apr       Impact factor: 3.019

6.  Comorbidities increase complication rates in patients having arthroplasty.

Authors:  Nitin B Jain; Ulrich Guller; Ricardo Pietrobon; Thomas K Bond; Laurence D Higgins
Journal:  Clin Orthop Relat Res       Date:  2005-06       Impact factor: 4.176

7.  The effect of total shoulder arthroplasty on self-assessed health status is comparable to that of total hip arthroplasty and coronary artery bypass grafting.

Authors:  Richard S Boorman; Branko Kopjar; Edward Fehringer; R Sean Churchill; Kevin Smith; Frederick A Matsen
Journal:  J Shoulder Elbow Surg       Date:  2003 Mar-Apr       Impact factor: 3.019

8.  Characterizing the functional improvement after total shoulder arthroplasty for osteoarthritis.

Authors:  Edward V Fehringer; Branko Kopjar; Richard S Boorman; R Sean Churchill; Kevin L Smith; Frederick A Matsen
Journal:  J Bone Joint Surg Am       Date:  2002-08       Impact factor: 5.284

9.  The complex characteristics of 282 unsatisfactory shoulder arthroplasties.

Authors:  Amy K Franta; Tim R Lenters; Doug Mounce; Blazej Neradilek; Frederick A Matsen
Journal:  J Shoulder Elbow Surg       Date:  2007-05-16       Impact factor: 3.019

10.  The National Veterans Administration Surgical Risk Study: risk adjustment for the comparative assessment of the quality of surgical care.

Authors:  S F Khuri; J Daley; W Henderson; G Barbour; P Lowry; G Irvin; J Gibbs; F Grover; K Hammermeister; J F Stremple
Journal:  J Am Coll Surg       Date:  1995-05       Impact factor: 6.113

View more
  27 in total

Review 1.  Reverse total shoulder arthroplasty-from the most to the least common complication.

Authors:  Mazda Farshad; Christian Gerber
Journal:  Int Orthop       Date:  2010-09-25       Impact factor: 3.075

2.  Total shoulder arthroplasty in older patients: increased perioperative morbidity?

Authors:  Eric T Ricchetti; Joseph A Abboud; Andrew F Kuntz; Matthew L Ramsey; David L Glaser; Gerald R Williams
Journal:  Clin Orthop Relat Res       Date:  2011-04       Impact factor: 4.176

3.  What Are the Complications, Survival, and Outcomes After Revision to Reverse Shoulder Arthroplasty in Patients Older Than 80 Years?

Authors:  Eduard Alentorn-Geli; Nicholas J Clark; Andrew T Assenmacher; Brian T Samuelsen; Joaquín Sánchez-Sotelo; Robert H Cofield; John W Sperling
Journal:  Clin Orthop Relat Res       Date:  2017-07-11       Impact factor: 4.176

4.  Low Serum Albumin Levels are Associated with Increased 30-Day Cardiopulmonary Complications, Reoperation, and Readmission Rates Following Total Shoulder Arthroplasty.

Authors:  Danny Lee; Ryan Lee; Megan T Cross; Andrew Tran; Jason Kappa; Sam Moghtaderi
Journal:  Iowa Orthop J       Date:  2019

5.  What Are Risk Factors for 30-day Morbidity and Transfusion in Total Shoulder Arthroplasty? A Review of 1922 Cases.

Authors:  Chris A Anthony; Robert W Westermann; Yubo Gao; Andrew J Pugely; Brian R Wolf; Carolyn M Hettrich
Journal:  Clin Orthop Relat Res       Date:  2014-12-19       Impact factor: 4.176

6.  Neuropathic Pain after Shoulder Arthroplasty: Prevalence, Impact on Physical and Mental Function, and Demographic Determinants.

Authors:  Helen Razmjou; Linda J Woodhouse; Richard Holtby
Journal:  Physiother Can       Date:  2018       Impact factor: 1.037

7.  Incidence, Causes and Predictors of 30-Day Readmission After Shoulder Arthroplasty.

Authors:  Robert W Westermann; Chris A Anthony; Kyle R Duchman; Andrew J Pugely; Yubo Gao; Carolyn M Hettrich
Journal:  Iowa Orthop J       Date:  2016

8.  Total Shoulder Arthroplasty: Is Less Time in the Hospital Better?

Authors:  Kyle R Duchman; Chris A Anthony; Robert W Westermann; Andrew J Pugely; Yubo Gao; Carolyn M Hettrich
Journal:  Iowa Orthop J       Date:  2017

9.  Hospital readmissions after surgical treatment of proximal humerus fractures: is arthroplasty safer than open reduction internal fixation?

Authors:  Alan L Zhang; William W Schairer; Brian T Feeley
Journal:  Clin Orthop Relat Res       Date:  2014-04-15       Impact factor: 4.176

10.  Revision Total Shoulder Arthroplasty is Associated with Increased Thirty-Day Postoperative Complications and Wound Infections Relative to Primary Total Shoulder Arthroplasty.

Authors:  Venkat Boddapati; Michael C Fu; William W Schairer; Lawrence V Gulotta; David M Dines; Joshua S Dines
Journal:  HSS J       Date:  2017-09-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.